BrainsWay Ltd. (BWAY)Healthcare | Medical Devices | Jerusalem, Israel | NasdaqGM
11.51 USD
-0.41
(-3.440%) ⇩
(Oct. 14, 2026, 4 p.m.
EDT)
After hours: 11.51 |
Hot Take ↕ | Oct. 10, 2026, 4:01 a.m. EDT
The long-term outlook remains constructive, driven by a robust recovery trajectory where the stock has gained nearly 68% over the last six years, fueled by double-digit revenue and earnings growth. However, the immediate path forward is clouded by significant valuation compression; trading at 51x trailing earnings and 7.8x sales, the market is pricing in perfection, leaving little room for error. While the balance sheet is pristine with minimal debt and strong cash conversion, the free cash flow burn and the disconnect between the lofty analyst targets and current fundamentals create a fragile setup. The short-term rating is muted because the statistical forecast offers no directional clarity, and the recent price action shows the stock struggling to reclaim key moving averages, suggesting the rally may be pausing before resuming. Without a catalyst to bridge the gap between current prices and the $19 average target, the risk-reward profile tilts slightly negative for the near term, even if the business quality is sound. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.069707 |
| MSTL | 0.070448 |
| AutoETS | 0.071337 |
| AutoARIMA | 0.076799 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 6.91 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.626 |
| Excess Kurtosis | -0.54 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 9.008 |
| Revenue per Share | 1.563 |
| Market Cap | 463,311,904 |
| Trailing P/E | 50.04 |
| Forward P/E | 22.72 |
| Beta | 0.10 |
| Profit Margins | 15.55% |
| Website | https://www.brainsway.com |
As of Oct. 10, 2026, 4:01 a.m. EDT: Speculators are positioning for a moderate upside move, evidenced by heavy open interest in out-of-the-money calls (strikes 15.0 and 20.0) compared to negligible put volume. Implied volatility is significantly elevated for puts (2.96 ATM) versus calls (0.73 ATM), suggesting a fear premium or asymmetric risk perception despite the bullish positioning. The lack of put volume indicates a lack of hedging demand, while the call structure suggests bets on continued expansion rather than protection against a crash.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.49 |
| Address1 | 16 Hartum St |
| Address2 | Har Hotzvim |
| All Time High | 17.4 |
| All Time Low | 0.69 |
| Ask | 19.71 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 129,950 |
| Average Daily Volume3 Month | 122,714 |
| Average Volume | 122,714 |
| Average Volume10Days | 129,950 |
| Beta | 0.099 |
| Bid | 10.99 |
| Bid Size | 2 |
| Book Value | 1.973 |
| City | Jerusalem |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 11.51 |
| Current Ratio | 3.591 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 11.79 |
| Day Low | 11.47 |
| Debt To Equity | 9.008 |
| Display Name | BrainsWay |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,786,608,000 |
| Earnings Call Timestamp Start | 1,786,608,000 |
| Earnings Growth | 0.598 |
| Earnings Quarterly Growth | 0.337 |
| Earnings Timestamp | 1,786,537,800 |
| Earnings Timestamp End | 1,794,313,800 |
| Earnings Timestamp Start | 1,794,313,800 |
| Ebitda | 8,483,000 |
| Ebitda Margins | 0.13976 |
| Enterprise To Ebitda | 47.968 |
| Enterprise To Revenue | 6.704 |
| Enterprise Value | 406,914,496 |
| Eps Current Year | 0.30667 |
| Eps Forward | 0.50667 |
| Eps Trailing Twelve Months | 0.23 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 13.9738 |
| Fifty Day Average Change | -2.4637995 |
| Fifty Day Average Change Percent | -0.17631564 |
| Fifty Two Week Change Percent | 49.0 |
| Fifty Two Week High | 17.4 |
| Fifty Two Week High Change | -5.8899994 |
| Fifty Two Week High Change Percent | -0.33850572 |
| Fifty Two Week Low | 7.135 |
| Fifty Two Week Low Change | 4.375 |
| Fifty Two Week Low Change Percent | 0.6131745 |
| Fifty Two Week Range | 7.135 - 17.4 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,555,507,800,000 |
| Float Shares | 24,095,704 |
| Forward Eps | 0.50667 |
| Forward P E | 22.716957 |
| Free Cashflow | -6,157,500 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 129 |
| Fullday Change | -0.40999985 |
| Fullday Change Percent | -3.439596 |
| Fullday Price | 11.51 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.75324 |
| Gross Profits | 45,718,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.02589 |
| Held Percent Institutions | 0.29638 |
| Implied Shares Outstanding | 40,252,989 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ir Website | http://www.brainsway.com/Brainsway/Templates/ShowPage.asp?DBID=1&LNGID=1&TMID=84&FID=540 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,772,582,400 |
| Last Split Factor | 2:1 |
| Long Business Summary | BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel. |
| Long Name | BrainsWay Ltd. |
| Market | us_market |
| Market Cap | 463,311,904 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_34280817 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 9,441,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 553,938,530 |
| Number Of Analyst Opinions | 3 |
| Open | 11.7 |
| Operating Cashflow | 7,570,000 |
| Operating Margins | 0.13977 |
| Payout Ratio | 0.0 |
| Phone | 972 2 582 4030 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 11.51 |
| Post Market Time | 1,792,008,015 |
| Previous Close | 11.92 |
| Price Eps Current Year | 37.5322 |
| Price Hint | 2 |
| Price To Book | 5.8337555 |
| Price To Sales Trailing12 Months | 7.6334443 |
| Profit Margins | 0.15555 |
| Quick Ratio | 3.049 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.41 |
| Regular Market Change Percent | -3.4396 |
| Regular Market Day High | 11.79 |
| Regular Market Day Low | 11.47 |
| Regular Market Day Range | 11.47 - 11.79 |
| Regular Market Open | 11.7 |
| Regular Market Previous Close | 11.92 |
| Regular Market Price | 11.51 |
| Regular Market Time | 1,792,008,001 |
| Regular Market Volume | 114,745 |
| Return On Assets | 0.040489998 |
| Return On Equity | 0.12817 |
| Revenue Growth | 0.354 |
| Revenue Per Share | 1.563 |
| Sand P52 Week Change | 0.1570785 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 40,252,989 |
| Shares Percent Shares Out | 0.0062 |
| Shares Short | 250,485 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 208,111 |
| Short Name | Brainsway Ltd. |
| Short Percent Of Float | 0.0082 |
| Short Ratio | 2.78 |
| Source Interval | 15 |
| Symbol | BWAY |
| Target High Price | 20.0 |
| Target Low Price | 18.8 |
| Target Mean Price | 19.26667 |
| Target Median Price | 19.0 |
| Total Cash | 62,108,000 |
| Total Cash Per Share | 1.548 |
| Total Debt | 7,133,000 |
| Total Revenue | 60,695,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.23 |
| Trailing P E | 50.04348 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 13.862312 |
| Two Hundred Day Average Change | -2.352312 |
| Two Hundred Day Average Change Percent | -0.16969118 |
| Type Disp | Equity |
| Volume | 114,745 |
| Website | https://www.brainsway.com |
| Zip | 9,777,516 |